U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07732426) titled 'Effects of Semaglutide on Brain Dopamine Responses to Food Cues in Adults With Obesity and Food Addiction Tendencies' on July 16.
Brief Summary: The goal of this clinical trial is to investigate how semaglutide affects the way the brain responds to food in adults with obesity and food addiction tendencies.
The main goals of this study are:
* To see if semaglutide changes dopamine-related activity in the brain during the look, smell, and drink period.
* To see if semaglutide changes dopamine-related brain signals during the post-ingestive period.
* To see if semaglutide changes psychological survey results and cognitive task resu...